BackgroundAlzheimer's disease (AD) is the most common form of dementia, marked by progressive cognitive decline. Low-density lipoprotein cholesterol (LDL-C) has been implicated in AD pathology, but fi Show more
BackgroundAlzheimer's disease (AD) is the most common form of dementia, marked by progressive cognitive decline. Low-density lipoprotein cholesterol (LDL-C) has been implicated in AD pathology, but findings remain inconsistent. Apolipoprotein E4 (APOE4) status and sex may contribute to this variability.ObjectiveTo examine how LDL-C association with neurodegeneration in AD patients, differ according to APOE4 status and gender.MethodsWe stratified 106 AD patients by APOE4 status and sex into four subgroups: male APOE4+, female APOE4+, male APOE4-, and female APOE4-. Longitudinal cortical thickness changes were assessed using magnetic resonance imaging (MRI). We examined the association between LDL-C levels and cortical thinning within each subgroup.ResultsIn APOE4-positive females, higher LDL-C levels were significantly associated with accelerated cortical thinning in several regions, including the parahippocampal (ฮฒโ=โ-0.0075, pโ=โ0.017), medial orbitofrontal (ฮฒโ=โ-0.0025, pโ=โ0.028), fusiform (ฮฒโ=โ-0.0047, pโ=โ0.034), posterior cingulate (ฮฒโ=โ-0.0097, pโ=โ0.006), and inferior temporal cortices (ฮฒโ=โ-0.0085, pโ=โ0.019). This subgroup also showed a significant association between LDL-C and MMSE decline (ฮฒโ=โ-1.409, pโ=โ0.014) as well as longitudinal increases in cerebrospinal fluid phosphorylated tau181 (ฮฒโ=โ0.014, pโ=โ0.039). These effects were not observed in other subgroups.ConclusionsElevated LDL-C is associated with increased neurodegeneration and cognitive decline in female AD patients carrying the APOE4 allele. These exploratory findings highlight a subgroup-specific vulnerability to lipid-related neurodegeneration in AD and underscore the importance of considering both sex and genetic background in future studies. Show less
BackgroundMetformin has been proposed to have neuroprotective benefits, but its effects on AD-related brain changes remain unclear and may be influenced by apolipoprotein E ฮต4 (